首页 | 本学科首页   官方微博 | 高级检索  
     

原发性乳腺恶性淋巴瘤13例临床分析
引用本文:刘艳,张清媛,李洪滨,赵曙. 原发性乳腺恶性淋巴瘤13例临床分析[J]. 黑龙江医学, 2005, 29(8): 593-594
作者姓名:刘艳  张清媛  李洪滨  赵曙
作者单位:哈尔滨医科大学第二临床医学院,黑龙江,哈尔滨,150086;哈尔滨医科大学附属肿瘤医院,黑龙江,哈尔滨,150040
摘    要:目的分析原发性乳腺恶性淋巴瘤(PBL)的临床病理特点、诊断、治疗方法及其预后。方法对13例PBL的临床特征、诊断情况和治疗方法进行回顾性分析。结果13例均为女性,均为弥漫性非霍奇金淋巴瘤(NHL),92.3%为B细胞来源,7.69%为T细胞来源,中位年龄45岁。总5年生存率为66.7%,Ⅰ+Ⅱ期5年生存率为75%。结论PBL的预后与分期和治疗方式有关,手术+化疗、放疗的综合治疗模式较好,局部切除应作为手术治疗的首选。

关 键 词:肿瘤学  乳腺肿瘤  淋巴瘤  治疗  预后
文章编号:1004-5775(2005)08-0593-02
收稿时间:2005-05-24
修稿时间:2005-05-24

Clinical Analysis of 13 Cases Primary Breast Lymphoma
Liu Yan;Zhang QingYuan;Li HongBin;Zhao Shu. Clinical Analysis of 13 Cases Primary Breast Lymphoma[J]. Heilongjiang Medical Journal, 2005, 29(8): 593-594
Authors:Liu Yan  Zhang QingYuan  Li HongBin  Zhao Shu
Abstract:Objective To analyze the clinical pathological characteristics, diagnosis treatment and prognosis factors in primary breast lymphoma (PBL). Methods The clinical data of 13 cases PBL were analyzed retrospectively. Results All patients were female with average age of 45. All cases were diffuse non-Hodgkin lymphoma with B-cell lineage 92.3% and T-cell lineage 7.69%. The overall 5-year survival rate was 66.7% for the whole group 75% for stage I and stage II disease. Conclusion The prognosis of PBL might be related with the stage and treatment modality. Operation combined with chemoradiotherapy might be a best treatment method. Local excision should be the first choice in surgery treatment.
Keywords:Beastneoplasm  Lymphoma  Treatment  Prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号